Truist Securities Maintains Buy on Exponent, Lowers Price Target to $110
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Tobey Sommer has maintained a 'Buy' rating on Exponent (NASDAQ:EXPO) but lowered the price target from $120 to $110.
July 31, 2023 | 3:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Exponent's price target has been lowered from $120 to $110 by Truist Securities, though the 'Buy' rating is maintained.
The lowering of the price target by Truist Securities could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the stock, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100